Completing data — refresh the page later to see the latest
145645-62-1Cl.O=C(O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1YZYRTEYMUTWJPL-UHFFFAOYSA-Nstructure in first source
145645-62-1DTXSID20163126CHEMBL545050Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Drugs used to prevent SEIZURES or reduce their severity.
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS.
UsesNNC 711 is an anticonvulsant agent and a selective GABA uptake inhibitor (1,2).
UsesNO-711 hydrochloride is suitable for use as γ-aminobutyric acid (GABA) transporter-1 (GAT-1) antagonists or GABA uptake inhibitor.